GMS Holdings invests $8.49 million in Strides Shasun’s biotech arm

24 Feb 2016 Evaluate

GMS Holdings has made the first tranche of investment of $8.49 million in Strides Shasun’s biotech arm Stelis Biopharma. The Jordan-based investment firm has made the investment through its subsidiary GMS Pharma (Singapore).

In 2014, Strides had entered into an agreement with GMS Holdings to make investments worth $21.90 million for 25.1 per cent stake in Stelis Biopharma.

Strides Shasun (formerly known as Strides Arcolab) is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.

Strides Pharma Scien Share Price

878.00 4.85 (0.56%)
17-Dec-2025 10:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1778.30
Dr. Reddys Lab 1271.55
Cipla 1495.55
Zydus Lifesciences 917.20
Lupin 2114.60
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×